{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:17:07Z","timestamp":1790975827796,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jaad.2020.06.055","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T01:56:23Z","timestamp":1592790983000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study"],"prefix":"10.1016","volume":"85","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Surprenant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Kempers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Pariser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Rensfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Tavakkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.06.055_bib1","author":"Novartis. LAMISIL"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2020.06.055_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0190-9622(97)70111-7","article-title":"Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial","volume":"37","author":"Drake","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2020.06.055_bib3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/jdv.13677","article-title":"The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians' offices","volume":"30","author":"Gupta","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2020.06.055_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CMR.11.3.415","article-title":"Onychomycosis: pathogenesis, diagnosis, and management","volume":"11","author":"Elewski","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.jaad.2020.06.055_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","article-title":"Onychomycosis: treatment and prevention of recurrence","volume":"80","author":"Lipner","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.06.055_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40257-013-0056-2","article-title":"Oral therapy for onychomycosis: an evidence-based review","volume":"15","author":"de S\u00e1","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2020.06.055_bib7","doi-asserted-by":"crossref","unstructured":"Gupta AK, Stec N, Summerbell RC, et\u00a0al. Onychomycosis: a review [e-pub ahead of print]. J Eur Acad Dermatol. doi:10.1111\/jdv.16394. Accessed April 23, 2020.","DOI":"10.1111\/jdv.16394"},{"issue":"3","key":"10.1016\/j.jaad.2020.06.055_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cpm.2016.02.001","article-title":"Onychomycosis","volume":"33","author":"Vlahovic","year":"2016","journal-title":"Clin Podiatr Med Surg"},{"issue":"1","key":"10.1016\/j.jaad.2020.06.055_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40257-018-0403-4","article-title":"A practical guide to curing onychomycosis: how to maximize cure at the patient, organism, treatment, and environmental level","volume":"20","author":"Gupta","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.06.055_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"Ghannoum","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.06.055_bib11","series-title":"Medical Mycology: Current Trends and Future Prospects","first-page":"28","article-title":"Onychomycosis: diagnosis and therapy","author":"Lipner","year":"2015"},{"issue":"3","key":"10.1016\/j.jaad.2020.06.055_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.04.062","article-title":"Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents","volume":"62","author":"Piraccini","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.06.055_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.138.3.353","article-title":"Long-term effectiveness of treatment with terbinafine vs. itraconazole in onychomycosis: a 5-year blinded prospective follow-up study","volume":"138","author":"Sigurgeirsson","year":"2002","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2020.06.055_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000017990","article-title":"Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up","volume":"197","author":"Tosti","year":"1998","journal-title":"Dermatol Basel Switz"},{"issue":"4 Suppl","key":"10.1016\/j.jaad.2020.06.055_bib16","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.06.055_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2020.06.055_bib19","first-page":"815","article-title":"The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials","volume":"13","author":"Gupta","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.06.055_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2015.04.010","article-title":"Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: results from 2 randomized phase-III studies","volume":"73","author":"Elewski","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2020.06.055_bib22","first-page":"AB132","article-title":"An open, single center pilot study of efficacy and safety of topical MOB015B in the treatment of distal subungual onychomycosis. Abstract 963. Poster presented at: American Academy of Dermatology 2015 Annual Meeting, March 20, 2015; San Francisco, CA","volume":"72","author":"Faergemann","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.06.055_bib23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1439-0507.2012.02215.x","article-title":"Treatment of distal subungual onychomycosis with a topical preparation of urea, propylene glycol and lactic acid: results of a 24-week, double-blind, placebo-controlled study","volume":"55","author":"Emtestam","year":"2012","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.jaad.2020.06.055_bib24","first-page":"311","article-title":"Comparison of the in\u00a0vitro activity of terbinafine and lanoconazole against dermatophytes","volume":"53","author":"Ghannoum","year":"2010","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.jaad.2020.06.055_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jaad.2006.12.019","article-title":"Onychomycosis: diagnosis and definition of cure","volume":"56","author":"Scher","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.06.055_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjopharm.2005.12.012","article-title":"Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in improving results in Onychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial","volume":"4","author":"Tavakkol","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"10.1016\/j.jaad.2020.06.055_bib27","first-page":"302","article-title":"The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence","volume":"4","author":"Gupta","year":"2005","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220311531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220311531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T19:24:17Z","timestamp":1724786657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220311531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0190962220311531"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.06.055","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.06.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}